Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Arena Pharmaceuticals
Special Reports
Top 10 biopharma M&A deals in 2021
PwC said that 2021 represented a "more normal year of M&A investing" that included some level of deferred M&A from the previous year.
Phil Taylor
Jan 18, 2022 3:00am
Eisai will pull Belviq off U.S. shelves on cancer concerns
Feb 14, 2020 9:32am
Novo preps big obesity push, undeterred by its rivals' fates
Nov 21, 2017 11:57am
Chasing a payday, new drugmakers favor solo launches: report
Apr 17, 2017 11:22am
Arena dumps laggard weight-loss med Belviq onto partner Eisai
Jan 5, 2017 10:40am
